Our study in the normoglycemic heart failure model indicates that exosome stimulation through an increase in circulating adiponectin level should be one of the key mechanisms of such action of PPARγ agonists and provide the future opportunity of advanced therapeutic applications. Here, PPARG is linked to heart failure.